Article(id=1329835147056231345, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329835073559441697, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2024.02.015, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1692028800000, receivedDateStr=2023-08-15, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794987006200, onlineDateStr=2026-11-18, pubDate=1707494400000, pubDateStr=2024-02-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794987006200, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794987006200, creator=13701087609, updateTime=1794987006200, updator=13701087609, issue=Issue{id=1329835073559441697, tenantId=1146029695717560320, journalId=1319690329412173987, year='2024', volume='45', issue='2', pageStart='107', pageEnd='227', issueExtLink='null', onlineDate='null', pubDate='1707494400000', pubDateStr='2024-02-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794986988677, creator='13701087609', updateTime=1794988212209, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329840205898560208, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329835073559441697, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329840205902754513, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329835073559441697, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=198, endPage=203, ext={EN=ArticleExt(id=1329835147274335154, articleId=1329835147056231345, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Therapeutic drugs and research and development progress of graft-versus-host disease, columnId=1325221194584162830, journalTitle=World Clinical Drug, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Graft-versus-host disease (GVHD) is the most significant complication after allogeneic stem cell transplantation. Hormone drugs are the first choice for the treatment of GVHD, but they have limitations in clinical use. This paper reviewed the new GVHD therapeutic drugs and those under development, to provide a reference for clinical use.

, authors=Jiayi XU1, Yuehua BAO2, Yigang TONG1, *, Shan YE3, *, authorsList=Jiayi XU, Yuehua BAO, Yigang TONG, Shan YE, authorCompany=null, correspAuthors=Yigang TONG, Shan YE, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329835147509216180, articleId=1329835147056231345, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=移植物抗宿主病治疗药物及研发进展, columnId=1325221194743546384, journalTitle=世界临床药物, columnName=综述评论, runingTitle=null, highlight=null, articleAbstract=

移植物抗宿主病(graft-versus-host disease,GVHD)是异基因造血干细胞移植后最主要的并发症。激素类药物是治疗GVHD的首选药物,但在临床应用中有其局限性。该文就近年新上市的GVHD治疗药物和处在研发中的药物展开综述,为临床用药提供一定的借鉴。

, authors=徐嘉昳1, 鲍粤华2, 童贻刚1, *, 叶杉3, *, authorsList=徐嘉昳, 鲍粤华, 童贻刚, 叶杉, authorCompany=null, correspAuthors=童贻刚, 叶杉, authorNote=

徐嘉昳,硕士研究生,研究方向:生物信息学。

, correspAuthorsNote=
叶杉,知识产权总监,高级工程师,研究方向:药物研发信息与医药知识产权。
童贻刚,教授,博士生导师,研究方向:生物安全、生物信息学。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=i16pXN4dd7RFTrSsNa5Qug==, magXml=Pu71ZZyu+C57ZIYYJNpvwA==, pdfUrl=null, pdf=13GBtGzIzR7lwTb1RaWrjA==, pdfFileSize=1619397, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=v+Sw4H0RAshpgoAHkpmADA==, mapNumber=null, fund=null)}, authors=[Author(id=1329835147941229504, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835148016726978, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, authorId=1329835147941229504, language=EN, stringName=Jiayi XU, firstName=Jiayi, middleName=null, lastName=XU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835148075447235, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, authorId=1329835147941229504, language=CN, stringName=徐嘉昳, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.北京化工大学生命科学与技术学院,北京 100029, bio={"content":"

徐嘉昳,硕士研究生,研究方向:生物信息学。

"}, bioImg=null, bioContent=

徐嘉昳,硕士研究生,研究方向:生物信息学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835147689571254, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, xref=1., ext=[AuthorCompanyExt(id=1329835147697959863, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, companyId=1329835147689571254, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China), AuthorCompanyExt(id=1329835147706348472, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, companyId=1329835147689571254, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.北京化工大学生命科学与技术学院,北京 100029)])]), Author(id=1329835148129973189, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835148213859271, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, authorId=1329835148129973189, language=EN, stringName=Yuehua BAO, firstName=Yuehua, middleName=null, lastName=BAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Hangzhou Biosun Pharmaceutical Co., LTD, Hangzhou 310011, Zhejiang Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835148285162440, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, authorId=1329835148129973189, language=CN, stringName=鲍粤华, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.杭州邦顺制药有限公司公司,浙江 杭州 310011, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835147765068729, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, xref=2., ext=[AuthorCompanyExt(id=1329835147769263034, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, companyId=1329835147765068729, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Hangzhou Biosun Pharmaceutical Co., LTD, Hangzhou 310011, Zhejiang Province, China), AuthorCompanyExt(id=1329835147777651643, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, companyId=1329835147765068729, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.杭州邦顺制药有限公司公司,浙江 杭州 310011)])]), Author(id=1329835148352271307, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329835148431963085, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, authorId=1329835148352271307, language=EN, stringName=Yigang TONG, firstName=Yigang, middleName=null, lastName=TONG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835148494877646, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, authorId=1329835148352271307, language=CN, stringName=童贻刚, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.北京化工大学生命科学与技术学院,北京 100029, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835147689571254, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, xref=1., ext=[AuthorCompanyExt(id=1329835147697959863, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, companyId=1329835147689571254, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China), AuthorCompanyExt(id=1329835147706348472, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, companyId=1329835147689571254, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.北京化工大学生命科学与技术学院,北京 100029)])]), Author(id=1329835148666844113, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329835148767507411, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, authorId=1329835148666844113, language=EN, stringName=Shan YE, firstName=Shan, middleName=null, lastName=YE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.Hangzhou Huadong Medicine Group Pharmaceutical Research Institute Co., LTD, Hangzhou 310011, Zhejiang Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835150394897364, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, authorId=1329835148666844113, language=CN, stringName=叶杉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.杭州华东医药集团新药研究院有限公司,浙江 杭州 310011, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835147836371900, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, xref=3., ext=[AuthorCompanyExt(id=1329835147848954813, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, companyId=1329835147836371900, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Hangzhou Huadong Medicine Group Pharmaceutical Research Institute Co., LTD, Hangzhou 310011, Zhejiang Province, China), AuthorCompanyExt(id=1329835147865732030, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, companyId=1329835147836371900, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.杭州华东医药集团新药研究院有限公司,浙江 杭州 310011)])])], keywords=[Keyword(id=1329835150520726486, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, language=EN, orderNo=1, keyword=graft-versus-host disease), Keyword(id=1329835150613001175, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, language=EN, orderNo=2, keyword=therapeutic drug), Keyword(id=1329835150684304344, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, language=EN, orderNo=3, keyword=research and development progress), Keyword(id=1329835150805939161, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, language=CN, orderNo=1, keyword=移植物抗宿主病), Keyword(id=1329835150889825242, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, language=CN, orderNo=2, keyword=治疗药物), Keyword(id=1329835150944351195, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, language=CN, orderNo=3, keyword=研发进展)], refs=[Reference(id=1329835151065986012, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Xu LP, Lu PH, Wu DP, et al. Hematopoietic stem cell transplantation activity in China 2019: a report from the Chinese Blood and Marrow Transplantation Registry Group[J]. Bone Marrow Transplant, 2021, 56(12): 2940-2947., articleTitle=null, refAbstract=null), Reference(id=1329835151149872093, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=中华医学会血液学分会干细胞应用学组. 中国异基因造血干细胞移植治疗血液系统疾病专家共识(Ⅲ)——急性移植物抗宿主病(2020年版)[J]. 中华血液学杂志, 2020, 41(7): 529-536., articleTitle=null, refAbstract=null), Reference(id=1329835151237952478, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=中华医学会血液学分会造血干细胞应用学组, 中国抗癌协会血液病转化委员会. 慢性移植物抗宿主病(cGVHD)诊断与治疗中国专家共识(2021年版)[J]. 中华血液学杂志, 2021, 42(4): 265-275., articleTitle=null, refAbstract=null), Reference(id=1329835151338615775, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Hill L, Alousi A, Kebriaei P, et al. New and emerging therapies for acute and chronic graft versus host disease[J]. Ther Adv Hematol, 2018, 9(1): 21-46., articleTitle=null, refAbstract=null), Reference(id=1329835151523165153, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Fiuza-Luces C, Garatachea N, Simpson RJ, et al. Understanding graft-versus-host disease. Preliminary findings regarding the effects of exercise in affected patients[J]. Exerc Immunol Rev, 2015, 21: 80-112., articleTitle=null, refAbstract=null), Reference(id=1329835151598662626, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Antin J, Ferrara J. Cytokine dysregulation and acute graft-versus-host disease[J]. Blood, 1992, 80(12): 2964-2968., articleTitle=null, refAbstract=null), Reference(id=1329835151720297444, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Kuba A, Raida L. Graft versus host disease: from basic pathogenic principles to DNA damage response and cellular senescence[J]. Mediators Inflamm, 2018, 2018: 9451950., articleTitle=null, refAbstract=null), Reference(id=1329835151804183525, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Busca A, Saroglia E, Lanino E, et al. Mycophenolate mofetil (MMF) as therapy for refractory chronic GVHD (cGVHD) in children receiving bone marrow transplantation[J]. Bone Marrow Transplant, 2000, 25(10): 1067-1071., articleTitle=null, refAbstract=null), Reference(id=1329835151883875302, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=朱雯. 西罗莫司联合钙调磷酸酶抑制剂治疗激素耐药/依赖的慢性移植物抗宿主病(cGVHD)[D]. 重庆: 中国人民解放军陆军军医大学, 2022., articleTitle=null, refAbstract=null), Reference(id=1329835151971955687, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Cragg L, Blazar BR, Defor T, et al. A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host disease[J]. Biol Blood Marrow Transplant, 2000, 6(4A): 441-447., articleTitle=null, refAbstract=null), Reference(id=1329835152081007592, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Jagasia M, Perales MA, Schroeder MA, et al. Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial[J]. Blood, 2020, 135(20): 1739-1749., articleTitle=null, refAbstract=null), Reference(id=1329835152152310761, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Dignan FL, Amrolia P, Clark A, et al. Diagnosis and management of chronic graft-versus-host disease[J]. Br J Haematol, 2012, 158(1): 46-61., articleTitle=null, refAbstract=null), Reference(id=1329835152227808234, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Flowers ME, Martin PJ. How we treat chronic graft-versus-host disease[J]. Blood, 2015, 125(4): 606-615., articleTitle=null, refAbstract=null), Reference(id=1329835152332665835, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Toubai T, Magenau J. Immunopathology and biology-based treatment of steroid-refractory graft-versus-host disease[J]. Blood, 2020, 136(4): 429-440., articleTitle=null, refAbstract=null), Reference(id=1329835152403969005, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Dubovsky JA, Flynn R, Du J, et al. Ibrutinib treatment ameliorates murine chronic graft-versus-host disease[J]. J Clin Invest, 2014, 124(11): 4867-4876., articleTitle=null, refAbstract=null), Reference(id=1329835152563352558, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=U. S. Food and Drug Administration. FDA expands ibrutinib indications to chronic GVHD[EB/OL]. (2017-08-02) [2023-07-10]. https://www.fda.gov/drugs/resources-information-approved-drugs/fda-expands-ibrutinib-indications-chronic-gvhd., articleTitle=null, refAbstract=null), Reference(id=1329835152634655727, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Miklos D, Cutler CS, Arora M, et al. Ibrutinib for chronic graft-versus-host disease after failure of prior therapy[J]. Blood, 2017, 130(21): 2243-2250., articleTitle=null, refAbstract=null), Reference(id=1329835152705958897, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Hechinger AK, Smith BAH, Flynn R, et al. Therapeutic activity of multiple common γ-chain cytokine inhibition in acute and chronic GVHD[J]. Blood, 2015, 125(3): 570-580., articleTitle=null, refAbstract=null), Reference(id=1329835152794039282, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Martini DJ, Chen YB, DeFilipp Z. Recent FDA approvals in the treatment of graft-versus-host disease[J]. Oncologist, 2022, 27(8): 685-693., articleTitle=null, refAbstract=null), Reference(id=1329835152911479795, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Przepiorka D, Luo L, Subramaniam S, et al. FDA approval summary: ruxolitinib for treatment of steroid-refractory acute graft-versus-host disease[J]. Oncologist, 2020, 25(2): e328-e334., articleTitle=null, refAbstract=null), Reference(id=1329835153117000692, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Zeiser R, Polverelli N, Ram R, et al. Ruxolitinib for glucocorticoid-refractory chronic graft-versus-host disease[J]. N Engl J Med, 2021, 385(3): 228-238., articleTitle=null, refAbstract=null), Reference(id=1329835153217663989, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Zeiser R, von Bubnoff N, Butler J, et al. Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease[J]. N Engl J Med, 2020, 382(19): 1800-1810., articleTitle=null, refAbstract=null), Reference(id=1329835154845053942, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Przepiorka D, Le RQ, Ionan A, et al. FDA approval summary: belumosudil for adult and pediatric patients 12 years and older with chronic GVHD after two or more prior lines of systemic therapy[J]. Clin Cancer Res, 2022, 28(12): 2488-2492., articleTitle=null, refAbstract=null), Reference(id=1329835154920551416, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Watkins B, Qayed M, McCracken C, et al. Phase Ⅱ trial of costimulation blockade with abatacept for prevention of acute GVHD[J]. J Clin Oncol, 2021, 39(17): 1865-1877., articleTitle=null, refAbstract=null), Reference(id=1329835155008631801, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Marcondes AM, Hockenbery D, Lesnikova M, et al. Response of steroid-refractory acute GVHD to α1-antitrypsin[J]. Biol Blood Marrow Transplant, 2016, 22(9): 1596-1601., articleTitle=null, refAbstract=null), Reference(id=1329835155084129274, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Clinical Trials. gov. The safety and efficacy of α-1 Antitrypsin (AAT) for the prevention of graft-versus-host disease (GVHD) in patients receiving hematopoietic cell transplant (MODULAATE)[EB/OL]. (2023-07-17) [2023-07-20]. https://www.clinicaltrials.gov/study/NCT03805789?term=NCT03805789&rank=1., articleTitle=null, refAbstract=null), Reference(id=1329835155180598268, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Clinical Trials. gov. Treatment of GVHD in hematopoietic stem cell transplant (HSCT) Recipients using AAT plus corticosteroids (CS) compared with corticosteroids alone (BMT CTN 1705)[EB/OL]. (2023-07-17) [2023-07-20]. https://www.clinicaltrials.gov/study/NCT04167514?term=NCT04167514&rank=1., articleTitle=null, refAbstract=null), Reference(id=1329835155323204605, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Clinical Trials. gov. Lactobacillus plantarum in preventing acute graft versus host disease in children undergoing donor stem cell transplant[EB/OL]. (2023-07-17) [2023-07-20]. https://clinicaltrials.gov/study/NCT03057054?cond=NCT03057054&rank=1., articleTitle=null, refAbstract=null), Reference(id=1329835155423867902, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Takeda Pharmaceutical Company. Takeda presents positive results from phase 3 study of vedolizumab for prevention of intestinal acute graft-versus-host disease (AGVHD) in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT)[EB/OL]. (2023-02-18) [2023-07-20]. https://www.takeda.com/newsroom/newsreleases/2023/takeda-presents-positive-results-from-phase-3-study-of-vedolizumab/., articleTitle=null, refAbstract=null), Reference(id=1329835155499365375, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=药物临床试验登记与信息公示平台. 盐酸杰克替尼片治疗激素难治性的急性移植物抗宿主病Ⅱ期临床试验[EB/OL]. (2023-02-18) [2023-07-20]. http://www.chinadrugtrials.org.cn/clinicaltrials.searchlistdetail.dhtml., articleTitle=null, refAbstract=null), Reference(id=1329835155616805888, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=Qiu H, Niu J, Sun X, et al. Phase Ⅰ study of SHR0302, a selective JAK1 inhibitor, combined with prednisone for first-line treatment of chronic graft-versus-host disease after allo-HSCT[J]. Blood, 2022, 140(Supplement 1): 7624., articleTitle=null, refAbstract=null), Reference(id=1329835155692302336, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=上海和誉生物医药科技有限公司. 和誉医药创新CSF-1R抑制剂Pimicotinib (ABSK021)获NMPA批准开展cGVHDⅡ期临床试验[EB/OL]. (2023-01-17) [2023-07-20]. https://www.abbisko.com/cn/newsDetail/138.html., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329835147689571254, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, xref=1., ext=[AuthorCompanyExt(id=1329835147697959863, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, companyId=1329835147689571254, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China), AuthorCompanyExt(id=1329835147706348472, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, companyId=1329835147689571254, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.北京化工大学生命科学与技术学院,北京 100029)]), AuthorCompany(id=1329835147765068729, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, xref=2., ext=[AuthorCompanyExt(id=1329835147769263034, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, companyId=1329835147765068729, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Hangzhou Biosun Pharmaceutical Co., LTD, Hangzhou 310011, Zhejiang Province, China), AuthorCompanyExt(id=1329835147777651643, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, companyId=1329835147765068729, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.杭州邦顺制药有限公司公司,浙江 杭州 310011)]), AuthorCompany(id=1329835147836371900, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, xref=3., ext=[AuthorCompanyExt(id=1329835147848954813, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, companyId=1329835147836371900, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Hangzhou Huadong Medicine Group Pharmaceutical Research Institute Co., LTD, Hangzhou 310011, Zhejiang Province, China), AuthorCompanyExt(id=1329835147865732030, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, companyId=1329835147836371900, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.杭州华东医药集团新药研究院有限公司,浙江 杭州 310011)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.02.015, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.02.015, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2024.02.015, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2024.02.015, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1707494400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
移植物抗宿主病治疗药物及研发进展
徐嘉昳 1 , 鲍粤华 2 , 童贻刚 1, * , 叶杉 3, *
世界临床药物 | 综述评论 2024,45(2): 198-203
收起
收藏切换
世界临床药物 |综述评论 2024 , 45 (2) : 198 -203
移植物抗宿主病治疗药物及研发进展
全屏
[Author(id=1329835147941229504, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835148016726978, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, authorId=1329835147941229504, language=EN, stringName=Jiayi XU, firstName=Jiayi, middleName=null, lastName=XU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835148075447235, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, authorId=1329835147941229504, language=CN, stringName=徐嘉昳, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.北京化工大学生命科学与技术学院,北京 100029, bio={"content":"

徐嘉昳,硕士研究生,研究方向:生物信息学。

"}, bioImg=null, bioContent=

徐嘉昳,硕士研究生,研究方向:生物信息学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835147689571254, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, xref=1., ext=[AuthorCompanyExt(id=1329835147697959863, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, companyId=1329835147689571254, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China), AuthorCompanyExt(id=1329835147706348472, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, companyId=1329835147689571254, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.北京化工大学生命科学与技术学院,北京 100029)])]), Author(id=1329835148129973189, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835148213859271, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, authorId=1329835148129973189, language=EN, stringName=Yuehua BAO, firstName=Yuehua, middleName=null, lastName=BAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Hangzhou Biosun Pharmaceutical Co., LTD, Hangzhou 310011, Zhejiang Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835148285162440, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, authorId=1329835148129973189, language=CN, stringName=鲍粤华, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.杭州邦顺制药有限公司公司,浙江 杭州 310011, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835147765068729, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, xref=2., ext=[AuthorCompanyExt(id=1329835147769263034, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, companyId=1329835147765068729, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Hangzhou Biosun Pharmaceutical Co., LTD, Hangzhou 310011, Zhejiang Province, China), AuthorCompanyExt(id=1329835147777651643, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, companyId=1329835147765068729, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.杭州邦顺制药有限公司公司,浙江 杭州 310011)])]), Author(id=1329835148352271307, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329835148431963085, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, authorId=1329835148352271307, language=EN, stringName=Yigang TONG, firstName=Yigang, middleName=null, lastName=TONG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835148494877646, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, authorId=1329835148352271307, language=CN, stringName=童贻刚, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.北京化工大学生命科学与技术学院,北京 100029, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835147689571254, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, xref=1., ext=[AuthorCompanyExt(id=1329835147697959863, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, companyId=1329835147689571254, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China), AuthorCompanyExt(id=1329835147706348472, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, companyId=1329835147689571254, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.北京化工大学生命科学与技术学院,北京 100029)])]), Author(id=1329835148666844113, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329835148767507411, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, authorId=1329835148666844113, language=EN, stringName=Shan YE, firstName=Shan, middleName=null, lastName=YE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.Hangzhou Huadong Medicine Group Pharmaceutical Research Institute Co., LTD, Hangzhou 310011, Zhejiang Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835150394897364, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, authorId=1329835148666844113, language=CN, stringName=叶杉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.杭州华东医药集团新药研究院有限公司,浙江 杭州 310011, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835147836371900, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, xref=3., ext=[AuthorCompanyExt(id=1329835147848954813, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, companyId=1329835147836371900, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Hangzhou Huadong Medicine Group Pharmaceutical Research Institute Co., LTD, Hangzhou 310011, Zhejiang Province, China), AuthorCompanyExt(id=1329835147865732030, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835147056231345, companyId=1329835147836371900, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.杭州华东医药集团新药研究院有限公司,浙江 杭州 310011)])])]
徐嘉昳1, 鲍粤华2, 童贻刚1, *, 叶杉3, *
作者信息
  • 1.北京化工大学生命科学与技术学院,北京 100029
  • 2.杭州邦顺制药有限公司公司,浙江 杭州 310011
  • 3.杭州华东医药集团新药研究院有限公司,浙江 杭州 310011
通讯作者:
叶杉,知识产权总监,高级工程师,研究方向:药物研发信息与医药知识产权。
童贻刚,教授,博士生导师,研究方向:生物安全、生物信息学。
作者简介:

徐嘉昳,硕士研究生,研究方向:生物信息学。

Therapeutic drugs and research and development progress of graft-versus-host disease
Jiayi XU1, Yuehua BAO2, Yigang TONG1, *, Shan YE3, *
Affiliations
  • 1.College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China
  • 2.Hangzhou Biosun Pharmaceutical Co., LTD, Hangzhou 310011, Zhejiang Province, China
  • 3.Hangzhou Huadong Medicine Group Pharmaceutical Research Institute Co., LTD, Hangzhou 310011, Zhejiang Province, China
出版时间: 2024-02-10 doi: 10.13683/j.wph.2024.02.015
文章导航
收藏切换

移植物抗宿主病(graft-versus-host disease,GVHD)是异基因造血干细胞移植后最主要的并发症。激素类药物是治疗GVHD的首选药物,但在临床应用中有其局限性。该文就近年新上市的GVHD治疗药物和处在研发中的药物展开综述,为临床用药提供一定的借鉴。

移植物抗宿主病  /  治疗药物  /  研发进展

Graft-versus-host disease (GVHD) is the most significant complication after allogeneic stem cell transplantation. Hormone drugs are the first choice for the treatment of GVHD, but they have limitations in clinical use. This paper reviewed the new GVHD therapeutic drugs and those under development, to provide a reference for clinical use.

graft-versus-host disease  /  therapeutic drug  /  research and development progress
徐嘉昳, 鲍粤华, 童贻刚, 叶杉. 移植物抗宿主病治疗药物及研发进展. 世界临床药物, 2024 , 45 (2) : 198 -203 . DOI: 10.13683/j.wph.2024.02.015
Jiayi XU, Yuehua BAO, Yigang TONG, Shan YE. Therapeutic drugs and research and development progress of graft-versus-host disease[J]. World Clinical Drug, 2024 , 45 (2) : 198 -203 . DOI: 10.13683/j.wph.2024.02.015

参考文献 引证文献
排序方式:
[1]
Xu LP, Lu PH, Wu DP, et al. Hematopoietic stem cell transplantation activity in China 2019: a report from the Chinese Blood and Marrow Transplantation Registry Group[J]. Bone Marrow Transplant, 2021, 56(12): 2940-2947.
[2]
中华医学会血液学分会干细胞应用学组. 中国异基因造血干细胞移植治疗血液系统疾病专家共识(Ⅲ)——急性移植物抗宿主病(2020年版)[J]. 中华血液学杂志, 2020, 41(7): 529-536.
[3]
中华医学会血液学分会造血干细胞应用学组, 中国抗癌协会血液病转化委员会. 慢性移植物抗宿主病(cGVHD)诊断与治疗中国专家共识(2021年版)[J]. 中华血液学杂志, 2021, 42(4): 265-275.
[4]
Hill L, Alousi A, Kebriaei P, et al. New and emerging therapies for acute and chronic graft versus host disease[J]. Ther Adv Hematol, 2018, 9(1): 21-46.
[5]
Fiuza-Luces C, Garatachea N, Simpson RJ, et al. Understanding graft-versus-host disease. Preliminary findings regarding the effects of exercise in affected patients[J]. Exerc Immunol Rev, 2015, 21: 80-112.
[6]
Antin J, Ferrara J. Cytokine dysregulation and acute graft-versus-host disease[J]. Blood, 1992, 80(12): 2964-2968.
[7]
Kuba A, Raida L. Graft versus host disease: from basic pathogenic principles to DNA damage response and cellular senescence[J]. Mediators Inflamm, 2018, 2018: 9451950.
[8]
Busca A, Saroglia E, Lanino E, et al. Mycophenolate mofetil (MMF) as therapy for refractory chronic GVHD (cGVHD) in children receiving bone marrow transplantation[J]. Bone Marrow Transplant, 2000, 25(10): 1067-1071.
[9]
朱雯. 西罗莫司联合钙调磷酸酶抑制剂治疗激素耐药/依赖的慢性移植物抗宿主病(cGVHD)[D]. 重庆: 中国人民解放军陆军军医大学, 2022.
[10]
Cragg L, Blazar BR, Defor T, et al. A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host disease[J]. Biol Blood Marrow Transplant, 2000, 6(4A): 441-447.
[11]
Jagasia M, Perales MA, Schroeder MA, et al. Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial[J]. Blood, 2020, 135(20): 1739-1749.
[12]
Dignan FL, Amrolia P, Clark A, et al. Diagnosis and management of chronic graft-versus-host disease[J]. Br J Haematol, 2012, 158(1): 46-61.
[13]
Flowers ME, Martin PJ. How we treat chronic graft-versus-host disease[J]. Blood, 2015, 125(4): 606-615.
[14]
Toubai T, Magenau J. Immunopathology and biology-based treatment of steroid-refractory graft-versus-host disease[J]. Blood, 2020, 136(4): 429-440.
[15]
Dubovsky JA, Flynn R, Du J, et al. Ibrutinib treatment ameliorates murine chronic graft-versus-host disease[J]. J Clin Invest, 2014, 124(11): 4867-4876.
[16]
U. S. Food and Drug Administration. FDA expands ibrutinib indications to chronic GVHD[EB/OL]. (2017-08-02) [2023-07-10]. https://www.fda.gov/drugs/resources-information-approved-drugs/fda-expands-ibrutinib-indications-chronic-gvhd.
[17]
Miklos D, Cutler CS, Arora M, et al. Ibrutinib for chronic graft-versus-host disease after failure of prior therapy[J]. Blood, 2017, 130(21): 2243-2250.
[18]
Hechinger AK, Smith BAH, Flynn R, et al. Therapeutic activity of multiple common γ-chain cytokine inhibition in acute and chronic GVHD[J]. Blood, 2015, 125(3): 570-580.
[19]
Martini DJ, Chen YB, DeFilipp Z. Recent FDA approvals in the treatment of graft-versus-host disease[J]. Oncologist, 2022, 27(8): 685-693.
[20]
Przepiorka D, Luo L, Subramaniam S, et al. FDA approval summary: ruxolitinib for treatment of steroid-refractory acute graft-versus-host disease[J]. Oncologist, 2020, 25(2): e328-e334.
[21]
Zeiser R, Polverelli N, Ram R, et al. Ruxolitinib for glucocorticoid-refractory chronic graft-versus-host disease[J]. N Engl J Med, 2021, 385(3): 228-238.
[22]
Zeiser R, von Bubnoff N, Butler J, et al. Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease[J]. N Engl J Med, 2020, 382(19): 1800-1810.
[23]
Przepiorka D, Le RQ, Ionan A, et al. FDA approval summary: belumosudil for adult and pediatric patients 12 years and older with chronic GVHD after two or more prior lines of systemic therapy[J]. Clin Cancer Res, 2022, 28(12): 2488-2492.
[24]
Watkins B, Qayed M, McCracken C, et al. Phase Ⅱ trial of costimulation blockade with abatacept for prevention of acute GVHD[J]. J Clin Oncol, 2021, 39(17): 1865-1877.
[25]
Marcondes AM, Hockenbery D, Lesnikova M, et al. Response of steroid-refractory acute GVHD to α1-antitrypsin[J]. Biol Blood Marrow Transplant, 2016, 22(9): 1596-1601.
[26]
Clinical Trials. gov. The safety and efficacy of α-1 Antitrypsin (AAT) for the prevention of graft-versus-host disease (GVHD) in patients receiving hematopoietic cell transplant (MODULAATE)[EB/OL]. (2023-07-17) [2023-07-20]. https://www.clinicaltrials.gov/study/NCT03805789?term=NCT03805789&rank=1.
[27]
Clinical Trials. gov. Treatment of GVHD in hematopoietic stem cell transplant (HSCT) Recipients using AAT plus corticosteroids (CS) compared with corticosteroids alone (BMT CTN 1705)[EB/OL]. (2023-07-17) [2023-07-20]. https://www.clinicaltrials.gov/study/NCT04167514?term=NCT04167514&rank=1.
[28]
Clinical Trials. gov. Lactobacillus plantarum in preventing acute graft versus host disease in children undergoing donor stem cell transplant[EB/OL]. (2023-07-17) [2023-07-20]. https://clinicaltrials.gov/study/NCT03057054?cond=NCT03057054&rank=1.
[29]
Takeda Pharmaceutical Company. Takeda presents positive results from phase 3 study of vedolizumab for prevention of intestinal acute graft-versus-host disease (AGVHD) in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT)[EB/OL]. (2023-02-18) [2023-07-20]. https://www.takeda.com/newsroom/newsreleases/2023/takeda-presents-positive-results-from-phase-3-study-of-vedolizumab/.
[30]
药物临床试验登记与信息公示平台. 盐酸杰克替尼片治疗激素难治性的急性移植物抗宿主病Ⅱ期临床试验[EB/OL]. (2023-02-18) [2023-07-20]. http://www.chinadrugtrials.org.cn/clinicaltrials.searchlistdetail.dhtml.
[31]
Qiu H, Niu J, Sun X, et al. Phase Ⅰ study of SHR0302, a selective JAK1 inhibitor, combined with prednisone for first-line treatment of chronic graft-versus-host disease after allo-HSCT[J]. Blood, 2022, 140(Supplement 1): 7624.
[32]
上海和誉生物医药科技有限公司. 和誉医药创新CSF-1R抑制剂Pimicotinib (ABSK021)获NMPA批准开展cGVHDⅡ期临床试验[EB/OL]. (2023-01-17) [2023-07-20]. https://www.abbisko.com/cn/newsDetail/138.html.
2024年第45卷第2期
20
5
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2024.02.015
  • 接收时间:2023-08-15
  • 首发时间:2026-11-18
  • 出版时间:2024-02-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2023-08-15
基金
作者信息
    1.北京化工大学生命科学与技术学院,北京 100029
    2.杭州邦顺制药有限公司公司,浙江 杭州 310011
    3.杭州华东医药集团新药研究院有限公司,浙江 杭州 310011

通讯作者:

叶杉,知识产权总监,高级工程师,研究方向:药物研发信息与医药知识产权。
童贻刚,教授,博士生导师,研究方向:生物安全、生物信息学。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.02.015
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏